MedTrace Logo

The Comparative Clinical Study of Gamisoyosan on Anxiety of Generalized Anxiety Disorder According to Dosage Form

NCT01285115 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 147

Last updated 2011-01-27

No results posted yet for this study

Summary

In this randomized, double blinded, Parallel-controlled study, the investigators planned to give Gamisoyosan extract, Gamisoyosan extract powder or controlled medication on Anxiety of generalized anxiety disorder according to dosage form.

Conditions

  • Generalized Anxiety Disorder

Interventions

DRUG

Placebo

AC 30 min, three times a day each sack taken before or between meals, 7.67g for each sack, 8 weeks.

DRUG

KyungBangn-Gamisoyosan-x-gwarip

AC 30 min, three times a day each sack taken before or between meals, 7.67g for each sack, 8 weeks.

DRUG

KyungBangn Gamisoyosan

AC 30 min, three times a day each sack taken before or between meals, 7.67g for each sack, 8 weeks.

Sponsors & Collaborators

  • Korea Health Industry Development Institute

    lead OTHER_GOV

Principal Investigators

  • In-Chul Jung, Ph.D · Oriental Hospital of Daejon University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-12-31
Primary Completion
2010-06-30
Completion
2010-07-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01285115 on ClinicalTrials.gov